Winton Matthew
- SEC CIK
- 0001971400
In the past year, 2 open-market purchase filings worth $117.1K and no sales.
Current role at each company
- CRVO CervoMed Inc.Chief Commercial and Businessas of Feb 13, 2026
- INZY Inozyme Pharma, Inc.COOas of Jul 3, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $117.1K
- 2 filings
- Sold
- –
- 0 filings
- Net
- +$117.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Winton Matthew as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRVO CervoMed Inc.
Chief Commercial and Business2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 19, 2025 (view filing) | Nov 17-18 | 2 days | Winton MatthewChief Commercial and Business | PPurchase | +5.00K | $8.29 | +$41.4K | +50.0%15.0K after | 2 lots |
| Nov 17, 2025 (view filing) | Nov 14 | 3 days | Winton MatthewChief Commercial and Business | PPurchase | +10.0K | $7.57 | +$75.7K | New position10.0K after |